Gen Cap America Inc said Oct. 2 that it acquired Orthopedic Physical Therapy Products. Management also invested. Financial terms weren’t announced. OPTP, of Minneapolis, provides physical therapy, fitness and wellness products.
2 min read · 02 October 2018
1 min read · 01 October 2018
Carlyle Group said Oct. 1 that Kara Helander has joined the firm as chief diversity officer. Helander previously served as managing director and global head of diversity & inclusion at BlackRock for ten years.
3 min read · 01 October 2018
H.I.G. Capital said Oct. 1 that it closed the sale of Lexmark Carpet Mills Inc to Tarkett SA. Financial terms weren’t announced. Lexmark, of Dalton, Georgia, provides flooring and sports surfaces.
3 min read · 01 October 2018
Sir Sandy Crombie has joined the board of LendingCrowd as chairman. Crombie is the former CEO of Standard Life. LendingCrowd, of Edinburgh, Scotland, is a fintech lender.
2 min read · 01 October 2018
Saba Software Inc, a portfolio company of Vector Capital, said Oct. 1 that it agreed to buy Lumesse. Financial terms weren’t announced. Lumesse, of Luton, England, provides talent solutions to organizations in more than 70 countries.
4 min read · 01 October 2018
Ara Partners Group said Oct. 1 that it acquired a majority stake in Centric Gas Services LLC. Financial terms weren’t announced. The Barnwell Family, which founded Centric's underlying entities in 1993, will continue to own a minority. Centric Gas, of Magnolia, Texas, operates four local gas distribution companies and three gas transmission pipeline companies in that state.
3 min read · 01 October 2018
Caris Life Sciences said Oct. 1 that it raised $150 million in growth capital in the form of senior secured debt and convertible notes from TPG Sixth Street Partners. Caris, of Irving, Texas, is developing next generation profiling of the whole genome, whole transcriptome and the complete cancer proteome.
4 min read · 01 October 2018
Omnes announced Oct. 1 staff promotions, including Frédéric Mimoun to senior director, along with several hires.
5 min read · 01 October 2018
Forbion said Oct. 1 that its latest flagship fund closed on 360 million euros ($418 million), above its 250 million ($290.2 million) original target. Forbion IV will focus on biopharma investment opportunities in the EU including the UK.
3 min read · 01 October 2018